Navigation Links
Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
Date:11/19/2008

MEDFORD, Mass., Nov. 19 /PRNewswire/ -- Serica Technologies, Inc., a growth-stage medical device company developing silk-based biomaterial platforms for tissue regeneration, today announced that it has received ISO 13485:2003 certification, meeting stringent international quality standards required for medical device manufacturers. ISO certification is the standard recognized and accepted by most regulatory bodies worldwide as proof of an effective quality system. The company's lead product, the SeriACL(TM), is currently in clinical development as a biocompatible and biodegradable ligament graft, for repair of the anterior cruciate ligament (ACL).

"Receiving ISO certification is a significant milestone for our company, and demonstrates our firm commitment to quality systems in the manufacture of our products," said Gregory H. Altman, Ph.D., President and CEO, Serica Technologies. "With this certification, Serica has taken another important step forward in establishing our company as the leader in silk-based biomaterial platforms for tissue repair."

This international standard specifies requirements for a quality management system wherein a company must demonstrate its ability to provide medical devices and related services that consistently meet both customer and regulatory requirements. "Certification is mandatory for regulatory approval of medical devices in many countries, and an important step towards our goal to commercialization in Europe," said Constance Garrison, Vice President, Regulatory Affairs and Quality Assurance, Serica Technologies.

Serica Secures $6 Million in New Financing

The company also announced today that it has closed on $6 million of additional funding, supported by existing investors, Morningside Technology Ventures, Prism VentureWorks and Ivy Capital Partners. The company has now raised a total of $23.5 million since its inception in 1998.

"Wit
'/>"/>

SOURCE Serica Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
11. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... DNA Genotek, a leading provider of produ...ced that Tepnel Pharmaceutical Services will offer...f its nucleic acid extraction and genotyping servi...December 1, 2009 -- DNA Genotek , a leading provi...today announced that Tepnel Pharmaceutical Servic...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of t...rade; Technologies, a business development and int...he emerging nanotechnology space. The company als...t as a nanotechnology incubator. , ... Michael R. Drapp , a 34-year veteran of the high...
(Date:11/30/2009)... YORK, Nov. 30 The Mich...FF) today announced $1.5 million in total awards t...y disease-modifying therapies for Parkinson,s dise...oaches to Drug Discovery for Parkinson,s Disease ...ation, plc (NYSE: ELN ), a neuroscience-based bi...
(Date:11/30/2009)... CHANGCHUN, China and LOS ANGELES, Nov. 30 /PRNe...icals, Inc. (OTC Bulletin Board: CYXN; ,China Yong...manufacturer, distributor and,retailer of pharmace...has,completed preparation for distribution of medi...hinese government recently formalized the nation,s...
Breaking Biology Technology:Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3
...be held on March 13, 2008 at 9:00 am (Eastern) ... Kong), SHANGHAI, China, Feb. 21 /Xinhua-PRNewswi...("WuXi PharmaTech" or "the Company"), the leading,...rch and development,outsourcing company, today ann...sults for the fourth quarter and full year ended D...
...LADELPHIA, February 21, Shire plc (LSE: SHP, NASDA...ompany announces results for the twelve months,to ...ant growth in launched,products., - All $ valu... Q4 2007 - Product sale... to $661m, - New product sales $489m, 23% of prod...
...to Follow, THE WOODLANDS, Texas, Feb. 20 Lexicon...se its fourth quarter and,year end 2007 financial ...cial markets close. Lexicon management will hold a...nt progress, financial results for 2007 and,financ... March 6, 2008., The dial-in number for the confe...
Other Biology Technology:WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008 2Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 2Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 3Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 4Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 5Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 6Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 7Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 8Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 9Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 10Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 11Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 12Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 13Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 14Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 15Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 16Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 17Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 18Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 19Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 20Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 21Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 22Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 23Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 24Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 25Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 26Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 27Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 28Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 29Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 30Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 31Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 32Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36% 33Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008 2
(Date:11/30/2009)..., VILNIUS, Lithuania, Nov. 30 N... a provider of high-precision biometric identifica...n the company,s core product line: VeriLook 4.0 ...ion and MegaMatcher 3.1 SDK for large-scale mult...on systems (AFIS). Expanded capabilities in VeriLo...
(Date:11/26/2009)...harks are some of the Ocean,s most distinctive res...e this strange head shape, says Michelle McComb f...on is the shark,s vision. ,Perhaps their visual fi...says McComb, giving the sharks excellent stereovis...Comb, there were two schools of thought on this th...
(Date:11/26/2009)...ave at last worked out a way of using recordings o...populations. This is the first time sound recordin...to accurate estimates of bird species, populations...sh Ecological Society,s Journal of Applied Ecolog...to a major advance in our ability to monitor whale...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Wide heads give hammerheads exceptional stereo view 2Ecologists sound out new solution for monitoring cryptic species 2Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases 5908 1Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases 5908 2Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases 5908 3Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call 5902 1Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call 5902 2Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call 5902 3Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call 5902 410 Ways to Get the Most out of Your Translation Service 3A Avantpage Reports on Industry Best Practices 60508 110 Ways to Get the Most out of Your Translation Service 3A Avantpage Reports on Industry Best Practices 60508 2
...ENO, Nev. If you couldn,t believe your eyes when ...aking 771-pound stingray, you may have been on to ...ere,s no denying that this is a huge stingray, the...ity of Nevada, Reno conservation biologist Zeb Hog... Project," a joint venture with the National Geogr...
...ientists have discovered how the toxoplasmosis par... and other bipolar disorders. , The team from the...es (UK) has shown that the parasite may play a rol...ng the production of dopamine - the chemical that ...f movement, cognition and behaviour. , Toxoplasmo...
...lymorphisms are variations in genes which can resu...ns and thus may be associated with susceptibility ...al Science , a journal of the Association for Psyc...nd her colleagues from the Karolinska Institutet i...ny examined the effect of specific polymorphisms o...
Other Biology News:Tall tale of giant stingray circles the globe 2Research supports toxoplasmosis link to schizophrenia 2The genetics of fear: Study suggests specific genetic variations contribute to anxiety disorders 2
...test entry in the Biomek line. With an,up-to-dat...and increased robustness, it can meet the needs of...with either one or two pipetting pods. With its la...d for flexible laboratory solutions to meet your c...
Biomek FX Laboratory Workstation (High Throughput) from Beckman Coulter
Mini Incubation Trays, 20 from Bio-Rad
Costar 96-Well Flat-Bottom EIA Plates, polystyrene, 100 from Bio-Rad
Biology Products: